Management Team

Medical Oncology

Overview

The Department of Medical And Precision Oncology at Sir H. N. Foundation Reliance Hospital is a centre of excellence, offering advanced treatment and diagnostic services for a wide range of solid tumours and hematologic malignancies

Our department has a highly skilled team of oncologists, researchers, genetic counsellors, molecular biologists, and oncology-trained support staff on a mission to transform cancer care by integrating advanced medical oncology treatment, clinical research, global collaborations, and a patient-centred, multidisciplinary approach, ensuring that each patient receives the most effective treatment tailored to their cancer type and individual needs. 

Our department emphasises comprehensive cancer care, supporting patients and their families at every stage of their journey through emotional and psychological support

Location: Level 3, Tower Building

Timings: 08:00 am to 08:00 pm

Request a call back

Fill in the details below and our advisor will get in touch with you in the next 24 hours

Name *
Email *
Mobile *
Enquire For *
Location *
Captcha
Enter the characters shown in the image.
The Tower

Precision Oncology Centre

The Precision Oncology Centre is revolutionising cancer treatment through cutting-edge cellular therapeutics, cancer vaccines, and molecular profiling, ensuring highly individualised therapies that enhance patient outcomes and exhibit reduced toxicity. By integrating precision medicine, advanced diagnostics, and next-generation immunotherapies, our centre tailors treatments based on each patient's unique tumour biology, maximising therapeutic effectiveness

  • A core pillar of our approach is our Molecular Tumour Board (MTB), which brings together oncologists, genetic counsellors, molecular biologists, immunologists, and clinical researchers to collaboratively analyse each patient's molecular data and recommend the most advanced, evidence-based treatments, including novel vaccine-based immunotherapies and cell-based therapeutics. This enables us to offer cutting-edge, personalised cancer care, ensuring that patients benefit from the collective expertise of specialists working together to optimise care.
  • Our centre has continuously advanced precision-driven oncology solutions and pushed the boundaries of cancer immunotherapy and regenerative medicine.
  • Recognised for pioneering contributions in molecular diagnostics, targeted therapies, and cellular immunotherapies, our centre has earned prestigious accolades.
  • By bridging scientific discovery and clinical applications, our centre aims to redefine the future of cancer treatment through innovation, collaboration, and compassionate care.

 

Haematology and Haemato-Oncology Centre

Our haematology and haemato-oncology centre focuses on the comprehensive care of patients with liquid tumours. We prioritise compassionate care, offering emotional support and comprehensive services for all patients.

  • We specialise in the diagnosis, treatment, and management of these haematological malignancies using advanced techniques and personalised care plans. We adopt a multidisciplinary approach, bringing together expert haematologists, oncologists, pathologists, and radiologists to ensure that each patient receives the most effective treatment.
  • Our services include cutting-edge diagnostic methods, chemotherapy, immunotherapy, radiation therapy, and stem cell transplantation.
  • Our Bone Marrow Transplant Unit is equipped to handle both autologous and allogeneic transplants, providing critical care for patients in need of this life-saving procedure.
  • Our centre is also at the forefront of innovative treatments, including CAR-T celltherapy, a ground-breaking treatment that harnesses the body's immune system, i.e., T cells, which help the body fight infections, to target and destroy cancer cells; this is particularly effective for certain types of blood cancers.
  • We prioritise holistic care, offering counselling, nutritional support, and rehabilitation services to improve the quality of life for our patients.
  • Through active involvement in clinical research and trials, we strive to offer the latest advancements in haemato-oncology treatments.
  • Our Haematology Program provides specialised care for patients with blood disorders.
  • Utilising advanced diagnostic tools, including blood tests, bone marrowbiopsies, genetic profiling, and imaging, we ensure precise and timely diagnoses.
  • Our team of haematologists works closely with patients to develop individualised treatment plans, ranging from medication management to advanced therapies, such as stem cell transplantation and targeted treatments.

 

Cancer Research and Treatment

Our cancer research and treatment team is recognised for its contributions to cancer research, clinical excellence, and innovation. Our team actively participates in high-impact clinical trials exploring novel therapeutic approaches, ensuring that our patients receive the most promising new treatments available.

Through partnerships with leading global research institutions and pharmaceutical companies, we remain at the forefront of oncology advancements. Our commitment to continuous learning and innovation ensures that we integrate breakthrough discoveries into patient care.

The Tower
  • Cancer Screening: Early cancer detection using advanced diagnostic methods.

 

  • Personalised treatment plans: Our department ensures that all patients receive one or more specific treatments most suited to their condition.
    • Targeted therapies: The use of specific medications that selectively attack cancer cells, with minimal damage to healthy cells.
    • Advanced immunotherapies: Cutting-edge treatments that modify the immune system and boost its ability to destroy cancer cells.
    • CAR-T cell therapy
    • Chemotherapy
    • Radiation therapy
    • Stem cell transplantation
    • Surgery
    • Hormonal therapy

 

  • Access to cutting-edge clinical trials for novel therapies and drug development.
  • Consultations with the molecular tumour board (MTB) and multidisciplinary tumour board (MDTB) for multidisciplinary care
  • Cancer care at home
  • Palliative care
  • Onco-Rehabilitation
  • Counselling
  • Dedicated nutritionists for cancer patients

 

  • Patient education and supportive care programs: These aim to address the physical, emotional, and psychological well-being of patients.
    • Personalised treatment education sessions during consultation
    • Psychosocial support and counselling
    • Survivorship programs and follow-up care
The Tower

SAARTHI is a comprehensive patient navigation program designed to guide patients through their healthcare journey. The program is focused on providing personalised assistance to patients diagnosed with complex medical conditions, particularly those undergoing cancer treatment.

  • SAARTHI’s dedicated patient navigators serve as a consistent point of contact, helping patients navigate the often-overwhelming healthcare system with ease.
  • From the moment a patient is diagnosed, the SAARTHI team works closely with them to offer guidance on treatment options, appointment scheduling, insurance processes, and access to financial or emotional support services.
  • The program ensures that patients are fully informed about their diagnosis, treatment plans, and any potential challenges that may arise, addressing any concerns along the way.
  • SAARTHI also focuses on providing psychosocial support, helping patients and their families cope with the emotional and mental challenges of a serious diagnosis.
  • Be it through counselling, support groups, or connecting patients with resources, SAARTHI empowers patients to actively participate in their treatment journey, ensuring that they feel supported, informed, and confident in their healthcare decisions.
The Tower

Our department specialises in treating a wide range of cancers:

  • Cancers associated with solid tumours, i.e., abnormal tissue masses, such as breast cancer, lung cancer, head and neck cancers, colorectal cancer, prostate cancer, ovarian and gynaecologic cancers, melanoma, pancreatic cancer, liver and biliary cancers, and renal cell and urothelial cancers.
  • Haematologic malignancies: These include various blood cancers.
    • Leukaemia
    • Lymphomas
    • Multiple myeloma
    • Myelodysplastic syndromes
    • Myeloproliferative disorders
  • Rare and/or advanced cancers
    • Soft-tissue sarcomas including specific subtypes with actionable mutations
    • Neuroendocrine tumours
    • Cancers of Unknown Primary (CUP)  with molecular profiling to determine actionable mutations

Partners In Care

Sewanti Limaye
Sewanti Limaye
Director
Medical Oncology
Sub-speciality: Medical Oncology - All Solid Tumours, Precision Oncology
  • M.B.B.S., M.D. (New York University, USA), M.S. (Columbia University, NY, USA)
  • 20+ years
Balkrishna Padate
Balkrishna Padate
Director and Co-Lead Cellular Therapies
Haematology
Sub-speciality: Haemato-Oncology, Bone Marrow Transplantation (BMT) and Cellular Therapy
  • M.D. (Medicine), MRCP (UK), FRCP (UK), FRCPATH (UK), CCST(UK)
  • 21+ years
Suresh Advani
Suresh Advani
Mentor
Medical Oncology
  • M.B.B.S., M.D. (General Medicine), FICP, MNAMS, FNAMS, UICC, IRCETT
  • 50+ years
Pritam Kataria
Pritam Kataria
Additional Director
Medical Oncology
  • M.B.B.S., M.D. (General Medicine), D.M. (Medical Oncology and Haemato-oncology)
  • 5+ years
Shweta Bansal
Shweta Bansal
Head - Paediatric Haemato-Oncology and Paediatric BMT
Haematology
Paediatric Hemato Oncology & BMT
Paediatric Transplant
Sub-speciality: Paediatric Haemato-Oncology & BMT
  • M.B.B.S., D.N.B. (Paediatrics)
  • 20+ years
Mohan Menon
Mohan Menon
Consultant
Medical Oncology
  • M.B.B.S., M.D. (General Medicine), American Board-certified in Medical Oncology, Hospice and Palliative care and Internal Medicine, M.B.A.
  • 23+ years
Vashishth Maniar
Vashishth Maniar
Consultant
Medical Oncology
Haematology
  • M.B.B.S., M.D. (General Medicine), D.M. (Medical Oncology and Haemato-Oncology)
  • 10+ years
Maheboob Mahamud Basade
Maheboob Mahamud Basade
Consultant
Medical Oncology
  • M.B.B.S., M.D. (Paediatrics)
  • 22+ years
Darshit K Shah
Darshit K Shah
Consultant
Medical Oncology
  • M.B.B.S., D.N.B. (Internal Medicine), D.M. (Medical Oncology), ECMO
  • 2+ years
Niyati K. Shah
Niyati K. Shah
Consultant
Medical Oncology
  • M.B.B.S, D.N.B (Internal Medicine), Dr.N.B (Medical Oncology)
  • 10+ years
Jyoti Bajpai
Jyoti Bajpai
Consultant
Medical Oncology
Sub-speciality: Precision Medicine and Immunotherapy
  • M.B.B.S., M.D. (General Medicine), D.M. (Medical Oncology)
  • 20+ years
Bottom to top